#wegovy

[ follow ]
#ozempic
www.nature.com
4 days ago
Medicine

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

Ozempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease. [ more ]
www.theguardian.com
5 days ago
Medicine

Women advised to pair effective contraception with skinny jabs'

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity. [ more ]
Nature
1 week ago
Medicine

Ozempic keeps wowing: trial data show benefits for kidney disease

Ozempic (Wegovy) reduces kidney failure & death risk in type 2 diabetes & kidney disease patients, broadening its health benefits. [ more ]
London Business News | Londonlovesbusiness.com
1 month ago
Business

Novo Nordisk Q1 results: 'Strong performance' and 'rosy outlook' expected

Investment in Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic led to record growth in Q4 2023. [ more ]
www.nytimes.com
1 month ago
Wellness

Opinion | This Is What a Miracle Drug Looks Like. And It Only Costs $5 to Make.

GLP-1 drugs like Ozempic and Wegovy have significant impact on weight loss and reducing the risk of heart disease, stroke, and other comorbidities. [ more ]
www.scientificamerican.com
1 month ago
Wellness

New Weight-Loss Drugs Are Meant to Be Lifelong. What Happens When You Quit?

Weight-loss drugs like Wegovy and Ozempic are popular but many users quit due to factors like cost, side effects, and limited coverage. [ more ]
moreozempic
#weight-loss
Inverse
2 weeks ago
Medicine

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects. [ more ]
WIRED
2 weeks ago
Medicine

Wegovy Can Keep Weight Off for at Least 4 Years, Research Shows

People on Wegovy experience steady weight loss for 65 weeks, maintaining initial loss over 4 years despite hitting a plateau. [ more ]
Ars Technica
2 weeks ago
Wellness

Long-term Wegovy study finds weight loss plateaus a little after a year

Weight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group. [ more ]
Entrepreneur
2 months ago
Wellness

Is Wegovy Covered By Insurance? These Insurers Offer Coverage | Entrepreneur

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.
The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%. [ more ]
moreweight-loss
#novo-nordisk
Entrepreneur
2 weeks ago
Wellness

Does Wegovy Work for Longterm Weight Loss? New Study Says Yes | Entrepreneur

Wegovy leads to 10% weight loss maintenance over four years for obesity patients without diabetes. [ more ]
Fast Company
1 month ago
Business

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Novo Nordisk's significant increase in Wegovy users and sales shows a growing demand for weight loss drugs. [ more ]
www.fastcompany.com
2 months ago
Health

Wegovy is no longer just a weight-loss drug

Wegovy was approved by the FDA to reduce the risk of major cardiovascular events in obese or overweight adults with established cardiovascular disease.
Wegovy has been shown to reduce the risk of major adverse cardiac events by 20%, cardiovascular death by 15%, and death from any cause by 19%. [ more ]
morenovo-nordisk
#obesity-treatment
www.npr.org
3 weeks ago
Wellness

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law. [ more ]
www.nytimes.com
2 months ago
Health

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes [ more ]
www.npr.org
2 months ago
Health

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity. [ more ]
moreobesity-treatment
#medicare-coverage
www.npr.org
2 months ago
Health

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes
Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits [ more ]
ABC7 San Francisco
2 months ago
Health

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans. [ more ]
moremedicare-coverage
Futurism
2 months ago
Health

Medicare Will Start Paying for Wegovy

Medicare may cover weight-loss drug Wegovy for select members with heart disease history
Wegovy assists in weight loss and reduces cardiovascular risk by around 20% [ more ]
#fda-approval
www.scientificamerican.com
2 months ago
Health

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works

Semaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individuals
The approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events [ more ]
time.com
2 months ago
Health

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%
Obesity drug Wegovy is a significant advancement in weight loss medication [ more ]
morefda-approval
www.nytimes.com
4 months ago
Medicine

Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs

The North Carolina State Health Plan has decided to end coverage for weight loss medications due to rising costs.
Appetite-suppressing drugs have been effective in helping patients lose weight and may prevent heart attacks and strokes, which can lead to high hospital bills. [ more ]
#Wegovy
The Atlantic
6 months ago
Health

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy. [ more ]
The Atlantic
6 months ago
Health

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy. [ more ]
moreWegovy
[ Load more ]